TIBOLLA, GIANPAOLO
 Distribuzione geografica
Continente #
EU - Europa 1.260
NA - Nord America 1.225
AS - Asia 1.133
SA - Sud America 110
AF - Africa 22
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.758
Nazione #
US - Stati Uniti d'America 1.196
GB - Regno Unito 439
CN - Cina 383
SG - Singapore 349
IT - Italia 213
DE - Germania 165
HK - Hong Kong 119
RU - Federazione Russa 99
SE - Svezia 89
BR - Brasile 77
VN - Vietnam 70
FR - Francia 61
NL - Olanda 59
IN - India 54
KR - Corea 37
BD - Bangladesh 34
TR - Turchia 31
FI - Finlandia 30
IE - Irlanda 29
UA - Ucraina 28
JP - Giappone 14
CA - Canada 12
AR - Argentina 11
ID - Indonesia 10
MX - Messico 9
GR - Grecia 8
EU - Europa 7
PL - Polonia 7
CO - Colombia 6
IQ - Iraq 6
MY - Malesia 6
AU - Australia 5
ZA - Sudafrica 5
BE - Belgio 4
CH - Svizzera 4
CL - Cile 4
DK - Danimarca 4
RO - Romania 4
VE - Venezuela 4
AT - Austria 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
EC - Ecuador 3
ES - Italia 3
KE - Kenya 3
MA - Marocco 3
PH - Filippine 3
PK - Pakistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
LB - Libano 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GH - Ghana 1
GL - Groenlandia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MT - Malta 1
NE - Niger 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.765
Città #
Southend 403
Singapore 212
Ashburn 137
Hong Kong 112
Beijing 88
San Jose 84
Chandler 74
Frankfurt am Main 62
Sunnyvale 61
Seattle 58
Mountain View 56
Milan 49
Santa Clara 48
Princeton 46
Dallas 43
Wilmington 43
Council Bluffs 35
Fairfield 34
Los Angeles 30
Dublin 29
Woodbridge 25
Redmond 24
Como 21
Grafing 21
Hanoi 20
Lauterbourg 20
Ann Arbor 19
Nanjing 19
Dearborn 17
Boardman 15
Moscow 15
Cangzhou 14
Columbus 14
New York 14
Berlin 13
Ho Chi Minh City 13
Shanghai 13
Tokyo 13
Des Moines 12
Kiez 12
San Francisco 12
Seoul 12
Shenyang 12
Guangzhou 11
Hangzhou 11
Bengaluru 10
Buffalo 10
Changsha 10
Houston 10
Jinan 9
The Dalles 9
Athens 8
Cambridge 8
Fuzhou 8
Helsinki 8
Munich 8
São Paulo 8
Genoa 7
Jacksonville 7
Jakarta 7
Medford 7
Veleso 7
Arzignano 6
Bitonto 6
Bogotá 6
Calolziocorte 6
Cantù 6
Redwood City 6
Sakarya 6
Eitensheim 5
Nanchang 5
Rome 5
Trento 5
Andover 4
Bexley 4
Edinburgh 4
Hebei 4
Montreal 4
Norwalk 4
Phoenix 4
Pisa 4
Renton 4
Rio de Janeiro 4
Somerville 4
Tianjin 4
Warsaw 4
Abidjan 3
Ankara 3
Belo Horizonte 3
Boston 3
Caracas 3
Central District 3
Chengdu 3
Cologno Monzese 3
Da Nang 3
Denver 3
Durham 3
Düsseldorf 3
Florence 3
Glasgow 3
Totale 2.393
Nome #
IDOL N342S variant, atherosclerosis progression and cardiovascular disorders in the Italian general population 292
Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency 280
Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels 257
Class II Phosphoinositide 3-Kinases Contribute to Endothelial Cells Morphogenesis 219
Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population 213
PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 SECRETED BY CULTURED SMOOTH MUSCLE CELLS REDUCES MACROPHAGES LOW DENSITY LIPOPROTEIN RECEPTOR LEVELS AND FACILITATES SMOOTH MUSCLE CELL MIGRATION 205
Targeting PCSK9 for Hypercholesterolemia 203
PCSK9 deficient mice are protected from neointima formation in carotid artery injury model 197
Proprotein convertase subtilisin kexin type 9 (PCSK9)secreted by cultured smooth muscle cells reduces macrophages LDLR levels 191
Proprotein convertase subtilisin/kexin type 9 (PCSK9): from structure-function relation to therapeutic inhibition 187
PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling 184
Dihydrotestosterone decreases tumor necrosis factor-(alpha) and lipopolysaccharide-induced inflammatory response in human endothelial cells 183
Expression and secretion of PCSK9 from cultured smooth muscle cells: evidence for a direct role in atherogenesis 178
Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels 175
Effect of proprotein convertase subtilisin kexin type 9 (PCSK9) on smooth muscle cell proliferation and migration 173
Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels 171
Statins and skeletal muscles toxicity: from clinical trials to everyday practice 169
PCSK9 inhibition for the treatment of hypercholesterolemia:pPromises and emerging challenges 165
HDL: To Treat or Not To Treat? 153
Gene silencing approaches for the management of dyslipidaemia 139
Totale 3.934
Categoria #
all - tutte 10.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.746


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 0 0 18
2021/2022208 18 5 7 3 20 14 20 9 15 24 19 54
2022/2023319 44 24 27 22 40 54 12 29 37 2 25 3
2023/2024202 2 13 17 27 63 3 4 5 4 18 15 31
2024/2025564 19 40 6 61 35 44 15 42 42 96 41 123
2025/20261.066 112 53 79 80 132 99 144 38 123 73 83 50
Totale 3.934